Susquehanna Portfolio Strategies’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-203,192
Closed -$1.79M 985
2023
Q4
$1.79M Buy
+203,192
New +$1.79M 0.03% 465